The Pharmaceutical Journal
Vol 279 No 7478 p551
17 November 2007

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Drugs achieve modest weight loss

On average, anti-obesity drugs achieve weight reductions of less than 5kg, a meta-analysis suggests (BMJ Online First, 16 November 2007).

Cardiovascular risk profiles differed across the agents studied: orlistat, sibutramine and rimonabant.